Back to search

Article

ADAM17 Deletion Protects Against Type1 Diabetes-Associated Kidney Injury by Modulating Inflammatory and Fibrotic Pathways

2026-02-08

Abstract excerpt

0 <h4>Background</h4> A Disintegrin and Metalloprotease 17 (ADAM17) is a key sheddase regulating multiple inflammatory and growth factor–related pathways implicated in diabetic kidney disease (DKD). While cell-specific deletion of ADAM17 has shown renoprotective effects, the impact of global ADAM17 ablation in the context of diabetes remains incompletely understood. <h4>Methods</h4> We investigated the effects o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2dce794e-7b34-5758-a9ae-5da4132a7e9a
DOI
10.64898/2026.02.05.704041
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ADAM17 Deletion Protects Against Type1 Diabetes-Associated Kidney Injury by Modulating Inflammatory and Fibrotic PathwaysDOI 10.64898/2026.02.05.704041
Select a neighboring publication to make it the new centre.